-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Navamedic ASA - Registration of share capital increase
19 Sep 2024 08:24 CEST
Issuer
Navamedic ASA
Oslo, 19 September 2024: Reference is made to the stock exchange announcement
published on 9 September 2024 by Navamedic ASA (the "Company") regarding the
board of directors' resolution to increase the Company's share capital in
connection with the exercise of employee share options. The share capital
increase pertaining to the exercised share options has now been registered with
the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The new
share capital of the Company is NOK 13,070,454.98, divided into 17,662,777
shares, each with a nominal value of NOK 0.74.
For further information, please contact: Lars Hjarrand, CFO, Navamedic, Mobile:
+47 917 62 842 E-mail: lars.hjarrand@navamedic.com
About Navamedic ASA: Navamedic ASA is a Nordic full-service provider of high
-quality products to hospitals and through pharmacies. Navamedic meets the
specific needs of patients and consumers by leveraging its highly scalable
market access platform, leading category competence and local knowledge.
Navamedic is present in all the Nordic countries, the Baltics and Benelux, with
sales representation in the UK and Greece. Navamedic is headquartered in Oslo,
Norway, and listed on the Oslo Stock Exchange (ticker: NAVA).
For more information, please visit www.navamedic.com.
This information is subject of the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
More information:
Access the news on Oslo Bors NewsWeb site
Source
Navamedic ASA
Provider
Oslo Børs Newspoint
Company Name
NAVAMEDIC
ISIN
NO0010205966
Symbol
NAVA
Market
Euronext Oslo Børs